Search - tctmd.com

Displaying 81 - 100 of 105

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Conference News EHRA 2025

Positive Results With Volt Pulsed-Field Ablation System

Todd Neale

April 07, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Daily News

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Caitlin E. Cox

March 25, 2025

News Daily News

Lower Risk of Mortality for Shock Patients Transferred to Expert Centers

Caitlin E. Cox

March 17, 2025

News Daily News

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Caitlin E. Cox

March 05, 2025

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

Todd Neale

February 27, 2025

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

Presentation THT 2025

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Presenter: Lucas Zier

February 13, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Presentation THT 2025

Worsening Renal Function Is Common And Associated With Increased Mortality In Cardiogenic Shock: An Analysis From The Multi-Center Cardiogenic Shock Working Group (CSWG) Registry

Presenter: Rachna Kataria

February 12, 2025

Presentation THT 2025

When to Use Devices the Recude Renal Vein Pressure

Presenter: Liviu Klein

February 12, 2025

News Conference News THT 2025

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Todd Neale

February 11, 2025

Presentation THT Abstracts 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT 2025

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Presenter: Jeffrey Testani

February 11, 2025

Presentation Miami Valves 2025

Initial Experience with the Symplicity Spiral Catheter for Renal Artery Denervation in the Dominican Republic

Presenter: Marcos Domínguez Vargas

January 30, 2025

News Daily News

High-Sensitivity Troponin Assays Not All the Same, APACE Data Confirm

Caitlin E. Cox

January 27, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

L.A. McKeown

January 16, 2025

Advertisement

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Positive Results With Volt Pulsed-Field Ablation System

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Lower Risk of Mortality for Shock Patients Transferred to Expert Centers

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

ACC/AHA Release New Comprehensive ACS Guidelines

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Worsening Renal Function Is Common And Associated With Increased Mortality In Cardiogenic Shock: An Analysis From The Multi-Center Cardiogenic Shock Working Group (CSWG) Registry

When to Use Devices the Recude Renal Vein Pressure

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Initial Experience with the Symplicity Spiral Catheter for Renal Artery Denervation in the Dominican Republic

High-Sensitivity Troponin Assays Not All the Same, APACE Data Confirm

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content